Insider Transactions in Q1 2022 at Lineage Cell Therapeutics, Inc. (LCTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Brian M Culley President and CEO |
BUY
Open market or private purchase
|
Direct |
6,400
+6.14%
|
$6,400
$1.53 P/Share
|
|
Mar 31
2022
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-5.52%
|
$5,343
$1.54 P/Share
|
|
Mar 31
2022
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+13.77%
|
-
|
|
Mar 28
2022
|
Dipti Amin |
BUY
Open market or private purchase
|
Direct |
35,000
+50.0%
|
$35,000
$1.63 P/Share
|
|
Mar 25
2022
|
Brian M Culley President and CEO |
BUY
Open market or private purchase
|
Direct |
5,250
+6.07%
|
$5,250
$1.38 P/Share
|
|
Mar 25
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Mar 25
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
470,000
+1.33%
|
$470,000
$1.44 P/Share
|
|
Mar 24
2022
|
Michael H. Mulroy |
BUY
Open market or private purchase
|
Direct |
7,000
+2.64%
|
$7,000
$1.4 P/Share
|
|
Mar 24
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Mar 24
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
200,000
+0.58%
|
$200,000
$1.42 P/Share
|
|
Mar 23
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Mar 23
2022
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
260,106
+0.75%
|
$260,106
$1.37 P/Share
|